These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 19031037)

  • 41. Examination of performance of the Center for Epidemiologic Studies Depression Scale Short Form 10 among African youth in poor, rural households.
    Kilburn K; Prencipe L; Hjelm L; Peterman A; Handa S; Palermo T
    BMC Psychiatry; 2018 Jun; 18(1):201. PubMed ID: 29914413
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic accuracy, internal consistency, and convergent validity of the Greek version of the patient health questionnaire 9 in diagnosing depression in rheumatologic disorders.
    Hyphantis T; Kotsis K; Voulgari PV; Tsifetaki N; Creed F; Drosos AA
    Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1313-21. PubMed ID: 21618450
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Validation of the Computerized Adaptive Test for Mental Health in Primary Care.
    Graham AK; Minc A; Staab E; Beiser DG; Gibbons RD; Laiteerapong N
    Ann Fam Med; 2019 Jan; 17(1):23-30. PubMed ID: 30670391
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening for depression in Andean Latin America: Factor structure and reliability of the CES-D short form and the PHQ-8 among Bolivian public hospital patients.
    Schantz K; Reighard C; Aikens JE; Aruquipa A; Pinto B; Valverde H; Piette JD
    Int J Psychiatry Med; 2017; 52(4-6):315-327. PubMed ID: 29108457
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Validation and calibration of the patient health questionnaire (PHQ-9) in Argentina.
    Urtasun M; Daray FM; Teti GL; Coppolillo F; Herlax G; Saba G; Rubinstein A; Araya R; Irazola V
    BMC Psychiatry; 2019 Sep; 19(1):291. PubMed ID: 31533674
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validation of screening tools for depression and anxiety disorders in a primary care population with high HIV prevalence in Zimbabwe.
    Chibanda D; Verhey R; Gibson LJ; Munetsi E; Machando D; Rusakaniko S; Munjoma R; Araya R; Weiss HA; Abas M
    J Affect Disord; 2016 Jul; 198():50-5. PubMed ID: 27011359
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Screening for psychological distress using the Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS): Initial validation of structural validity in dialysis patients.
    Chilcot J; Hudson JL; Moss-Morris R; Carroll A; Game D; Simpson A; Hotopf M
    Gen Hosp Psychiatry; 2018; 50():15-19. PubMed ID: 28985589
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of the 10-item Centre for Epidemiological Studies Depression Scale (CES-D-10) in Zulu, Xhosa and Afrikaans populations in South Africa.
    Baron EC; Davies T; Lund C
    BMC Psychiatry; 2017 Jan; 17(1):6. PubMed ID: 28068955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Validity of the Patient Health Questionnaire-9 to screen for depression in a high-HIV burden primary healthcare clinic in Johannesburg, South Africa.
    Cholera R; Gaynes BN; Pence BW; Bassett J; Qangule N; Macphail C; Bernhardt S; Pettifor A; Miller WC
    J Affect Disord; 2014; 167():160-6. PubMed ID: 24972364
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Psychometric properties and clinical utility of brief measures of depression, anxiety, and general distress: The PHQ-2, GAD-2, and K-6.
    Staples LG; Dear BF; Gandy M; Fogliati V; Fogliati R; Karin E; Nielssen O; Titov N
    Gen Hosp Psychiatry; 2019; 56():13-18. PubMed ID: 30508772
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluating the Psychometric Properties and Responsiveness to Change of 3 Depression Measures in a Sample of Persons With Traumatic Spinal Cord Injury and Major Depressive Disorder.
    Williams RT; Heinemann AW; Neumann HD; Fann JR; Forchheimer M; Richardson EJ; Bombardier CH;
    Arch Phys Med Rehabil; 2016 Jun; 97(6):929-37. PubMed ID: 26859610
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire (PHQ-9).
    Löwe B; Kroenke K; Herzog W; Gräfe K
    J Affect Disord; 2004 Jul; 81(1):61-6. PubMed ID: 15183601
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Validity of the Patient Health Questionnaire-9 in assessing depression following traumatic brain injury.
    Fann JR; Bombardier CH; Dikmen S; Esselman P; Warms CA; Pelzer E; Rau H; Temkin N
    J Head Trauma Rehabil; 2005; 20(6):501-11. PubMed ID: 16304487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psychometric Validation of PHQ-9 and GAD-7 in Filipino Migrant Domestic Workers in Macao (SAR), China.
    Garabiles MR; Lao CK; Yip P; Chan EWW; Mordeno I; Hall BJ
    J Pers Assess; 2020; 102(6):833-844. PubMed ID: 31361153
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening value of the Center for epidemiologic studies - depression scale among people living with HIV/AIDS in Ho Chi Minh City, Vietnam: a validation study.
    Thai TT; Jones MK; Harris LM; Heard RC
    BMC Psychiatry; 2016 May; 16():145. PubMed ID: 27178070
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychometric evaluation of two short versions of the Revised Child Anxiety and Depression Scale.
    Klaufus L; Verlinden E; van der Wal M; Kösters M; Cuijpers P; Chinapaw M
    BMC Psychiatry; 2020 Feb; 20(1):47. PubMed ID: 32024481
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Are two items sufficient to screen for depression within the hospital context?
    Osório FL; Carvalho AC; Fracalossi TA; Crippa JA; Loureiro ES
    Int J Psychiatry Med; 2012; 44(2):141-8. PubMed ID: 23413661
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Text Messaging as a Screening Tool for Depression and Related Conditions in Underserved, Predominantly Minority Safety Net Primary Care Patients: Validity Study.
    Jin H; Wu S
    J Med Internet Res; 2020 Mar; 22(3):e17282. PubMed ID: 32213473
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of the PHQ-9 and CES-D depression scales in systemic sclerosis: internal consistency reliability, convergent validity and clinical correlates.
    Milette K; Hudson M; Baron M; Thombs BD;
    Rheumatology (Oxford); 2010 Apr; 49(4):789-96. PubMed ID: 20100794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The accuracy of Patient Health Questionnaire-9 in detecting depression and measuring depression severity in high-risk groups in primary care.
    Wittkampf K; van Ravesteijn H; Baas K; van de Hoogen H; Schene A; Bindels P; Lucassen P; van de Lisdonk E; van Weert H
    Gen Hosp Psychiatry; 2009; 31(5):451-9. PubMed ID: 19703639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.